Download
s00063-020-00656-5.pdf 278,57KB
WeightNameValue
1000 Titel
  • Ärztliche Aufklärungspflichten nach Bekanntgabe eines Warnhinweises über unerwünschte Arzneimittelwirkungen
1000 Titelzusatz
  • Physician’s obligations to inform about complications based on a recent warning from drug authorities
1000 Autor/in
  1. Duttge, G. |
  2. Meyer, T. |
1000 Erscheinungsjahr 2020
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2020-02-07
1000 Erschienen in
1000 Quellenangabe
  • 116(4):332-338
1000 Copyrightjahr
  • 2020
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1007/s00063-020-00656-5 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8102277/ |
1000 Publikationsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Background!#!Based on a recent warning from the drug authorities about increased suicidality among users of hormonal contraceptives, this article discusses the legal consequences of translating novel findings from clinical trials into altered contents of gaining informed consent during the medical consultation.!##!Methods and results!#!Comprehensive information in accordance with § 630e German Civil Code (BGB) requires that rare drug reactions be mentioned by the prescribing physician, when they are associated with serious sequelae. This act regulates the treating physician's obligations to inform about complications for both preventive and curative treatment options. In this paper, we refer to the scientific evidence level of data from clinical trials as the key feature for implementing altered medical information in the proper conduct of acquiring the consent of the patient in line with § 630e BGB. The article discusses how additions and amendments to the package leaflet and the expert information will impact on the obligations for the treating party to provide information for the patient in order to obtain informed consent. In particular, we focus on the relationship between the obligations for the physician prescribing oral contraceptives on an individual case and the generalized information conditions according to § 11 and § 11a German Medicinal Products Act.!##!Discussion!#!Current warnings of the drug authorities in the form of red-hand letters do not necessarily have legal consequences for gaining informed consent during the medical consultation.
1000 Sacherschließung
lokal Physicians [MeSH]
lokal Suicidality
lokal Pharmaceutical Preparations [MeSH]
lokal Acquiring informed consent
lokal Humans [MeSH]
lokal Informed Consent [MeSH]
lokal Selbstbestimmungsaufklärung
lokal Hormonelle Kontrazeption
lokal Suizidalität
lokal Summary of product characteristics/package leaflets
lokal Depression
lokal Originalien
lokal § 630e German Civil Code
lokal Hormonal contraception
lokal Fach- und Gebrauchsinformationen für Arzneimittel
lokal § 630e Bürgerliches Gesetzbuch
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/RHV0dGdlLCBHLg==|https://frl.publisso.de/adhoc/uri/TWV5ZXIsIFQu
1000 Hinweis
  • DeepGreen-ID: c5e0229cc500409f8ec2d27070fe5a70 ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6441904.rdf
1000 Erstellt am 2023-04-26T11:43:25.595+0200
1000 Erstellt von 322
1000 beschreibt frl:6441904
1000 Zuletzt bearbeitet 2023-10-19T11:23:55.881+0200
1000 Objekt bearb. Thu Oct 19 11:23:55 CEST 2023
1000 Vgl. frl:6441904
1000 Oai Id
  1. oai:frl.publisso.de:frl:6441904 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source